Screening and control of methicillin-resistant Staphylococcus aureus in 186 intensive care units: Different situations and individual solutions

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Kohlenberg, Anke ^a   Schwab, Frank ^b,c   Behnke, Michael ^b,c   Geffers, Christine ^b,c   Gastmeier, Petra ^b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c National Reference Centre for Surveillance of Nosocomial Infections   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE SURVEILLANCE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; CROSS INFECTION; HEALTH CARE SURVEY; INCIDENCE; INFECTION CONTROL; METHODOLOGY; ORGANIZATION AND MANAGEMENT; STAPHYLOCOCCUS INFECTION; STATISTICAL MODEL;

CROSS INFECTION; HEALTH CARE SURVEYS; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; LINEAR MODELS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; QUESTIONNAIRES; STAPHYLOCOCCAL INFECTIONS;

EID: 82055171846     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10571     Document Type: Article

References (29)

1. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59. 10.1086/345476, 12491202.
2. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598. 10.1086/367653, 12594640.
3. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001, 29(Suppl 4):N64-N68.
4. Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997, 24:211-215. 10.1093/clinids/24.2.211, 9114149.
5. Kohlenberg A, Schwab F, Meyer E, Behnke M, Geffers C, Gastmeier P. Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis. J Hosp Infect 2009, 73:239-245. 10.1016/j.jhin.2009.07.017, 19804919.
6. Chaberny IF, Schwab F, Ziesing S, Suerbaum S, Gastmeier P. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. J Antimicrob Chemother 2008, 62:1422-1429. 10.1093/jac/dkn373, 18765411.
7. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, Renzi G, Vernaz N, Sax H, Pittet D. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157. 10.1001/jama.299.10.1149, 18334690.
8. Tacconelli E. Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. Clin Microbiol Infect 2009, 15(Suppl 7):31-38.
9. Clancy M, Graepler A, Wilson M, Douglas I, Johnson J, Price CS. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006, 27:1009-1017. 10.1086/507915, 17006806.
10. Harbarth S, Sax H, Uckay I, Fankhauser C, Agostinho A, Christenson JT, Renzi G, Schrenzel J, Pittet D. A predictive model for identifying surgical patients at risk of methicillin-resistant Staphylococcus aureus carriage on admission. J Am Coll Surg 2008, 207:683-689. 10.1016/j.jamcollsurg.2008.05.023, 18954780.
11. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Platt R. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006, 43:971-978. 10.1086/507636, 16983607.
12. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008, 46:1717-1725. 10.1086/587901, 18494098.
13. Struelens MJ, Hawkey PM, French GL, Witte W, Tacconelli E. Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin Microbiol Infect 2009, 15:112-119.
14. Tacconelli E, De Angelis G, de Waure C, Cataldo MA, La Torre G, Cauda R. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009, 9:546-554. 10.1016/S1473-3099(09)70150-1, 19695491.
15. Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, Dettenkofer M, Chaberny IF, Rüden H, Geffers C. Ten years of KISS: the most important requirements for success. J Hosp Infect 2008, 70(Suppl 1):11-16.
16. Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen Protection against Infection Act, paragraph 23. Bundesgesetzblatt 2011, 41:1622-1623. part 1.
17. Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA. STAR*ICU Trial Investigators: Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011, 364:1407-1418. 10.1056/NEJMoa1000373, 21488763.
18. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, Render ML, Freyberg RW, Jernigan JA, Muder RR, Miller LJ, Roselle GA. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011, 364:1419-1430. 10.1056/NEJMoa1007474, 21488764.
19. Harbarth S, Hawkey PM, Tenover F, Stefani S, Pantosti A, Struelens MJ. Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2011, 37:110-117. 10.1016/j.ijantimicag.2010.10.022, 21163628.
20. Peterson LR, Diekema DJ. To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2010, 48:683-689. 10.1128/JCM.02516-09, 2832433, 20071548.
21. Huang SS, Rifas-Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES, Cosgrove SE, Perl TM, Pottinger JM, Herwaldt LA, Jernigan JA, Tokars JL, Diekema DJ, Hinrichsen VL, Yokoe DS, Platt R, Centers for Disease Control and Prevention Epicenters Program Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007, 195:330-338. 10.1086/510622, 17205470, Centers for Disease Control and Prevention Epicenters Program.
22. Hansen S, Schwab F, Asensio A, Carsauw H, Heczko P, Klavs I, Lyytikäinen O, Palomar M, Riesenfeld-Orn I, Savey A, Szilagyi E, Valinteliene R, Fabry J, Gastmeier P. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken?. Infection 2010, 38:159-164. 10.1007/s15010-010-0001-8, 20232107.
23. Loveday HP, Pellowe CM, Jones SR, Pratt RJ. A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). J Hosp Infect 2006, 63(Suppl 1):S45-S70.
24. Gastmeier P, Schwab F, Geffers C, Rüden H. To isolate or not to isolate? Analysis of data from the German Nosocomial Infection Surveillance System regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 2004, 25:109-113. 10.1086/502359, 14994934.
25. Merrer J, Santoli F, Appéré de Vecchi C, Tran B, De Jonghe B, Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000, 21:718-723. 10.1086/501721, 11089656.
26. Schweickert B, Geffers C, Farragher T, Gastmeier P, Behnke M, Eckmanns T, Schwab F. The MRSA-import in ICUs is an important predictor for the occurrence of nosocomial MRSA cases. Clin Microbiol Infect 2011, 17:901-906. 10.1111/j.1469-0691.2010.03409.x, 20977541.
27. Nelson RE, Samore MH, Smith KJ, Harbarth S, Rubin MA. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect 2010, 16:1740-1746. 10.1111/j.1469-0691.2010.03324.x, 20673265.
28. Marshall C, Wesselingh S, McDonald M, Spelman D. Control of endemic MRSA-what is the evidence? A personal view. J Hosp Infect 2004, 56:253-268. 10.1016/j.jhin.2004.02.001, 15066735.
29. National Reference Center for Staphylococci at the Robert-Koch-Institute Auftreten und Verbreitung von MRSA in Deutschland 2010. Epidemiologisches Bulletin 2011, 26:233-241. National Reference Center for Staphylococci at the Robert-Koch-Institute.